Table 3 Multivariable logistic regression analysis of risk factors associated with MAKE30.
Characteristics | OR | 95% CI | p value |
|---|---|---|---|
Hospital-acquired AKI | 1.49 | 1.02–2.17 | 0.039 |
AKI stage | |||
Stage 1 | 1.00 | – | – |
Stage 2 | 9.42 | 6.58–13.49 | < 0.001 |
Stage 3 | 16.86 | 11.31–25.12 | < 0.001 |
Glomerulonephritis | 1.97 | 1.02–3.81 | 0.044 |
Shock | 1.98 | 0.99–3.96 | 0.05 |
Respiratory failure | 2.67 | 1.61–4.43 | < 0.001 |
Nephrotoxic drugs | 0.76 | 0.54–1.06 | 0.10 |
Platelets < 100 × 109/L | 1.42 | 0.98–2.06 | 0.07 |
Serum albumin < 30 g/L | 1.54 | 1.10–2.17 | 0.012 |
Serum total bilirubin > 34.2 mmol/L | 1.95 | 1.26–3.00 | 0.003 |
Serum potassium > 5.5 mmol/L | 2.02 | 1.14–3.58 | 0.015 |
